Imapct of FDA's Recent Guidance on Payer Communications

Presented by

Nathan White, Sr. VP Integrated Access & Outcomes Solutions; Sean P. Wagner, Sr. VP, Strategic & Client Services, ICON

About this talk

Our experts explore how manufacturers can successfully implement this guidance and integrate new communication channels with payers. This webinar will cover: - The history of FDAMA section 114 and rationale for amendment legislation - Differences between the draft and final FDA guidance - Industry and public concerns and questions - “CFL guidance” related to consistency of labelling in medical communications - Challenges with the promotional versus scientific exchange debate - Key opportunities and considerations for industry

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (35)
Subscribers (486)
BioPharma companies and Medical Devices manufacturers face growing operational, regulatory and economic challenges when it comes to developing their drug or device. ICON provides analysis and key insights on these challenges, with practical advice and recommendations.